PT1220676E - Prevencao do cancro colorrectal - Google Patents

Prevencao do cancro colorrectal

Info

Publication number
PT1220676E
PT1220676E PT00962269T PT00962269T PT1220676E PT 1220676 E PT1220676 E PT 1220676E PT 00962269 T PT00962269 T PT 00962269T PT 00962269 T PT00962269 T PT 00962269T PT 1220676 E PT1220676 E PT 1220676E
Authority
PT
Portugal
Prior art keywords
cancer
prostate
bladder
lung
prevention
Prior art date
Application number
PT00962269T
Other languages
English (en)
Inventor
Raskov Hans Henrik
Original Assignee
Coloctech As
Raskov Hans Henrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coloctech As, Raskov Hans Henrik filed Critical Coloctech As
Publication of PT1220676E publication Critical patent/PT1220676E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
PT00962269T 1999-09-29 2000-09-29 Prevencao do cancro colorrectal PT1220676E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199901390 1999-09-29

Publications (1)

Publication Number Publication Date
PT1220676E true PT1220676E (pt) 2005-08-31

Family

ID=8104340

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00962269T PT1220676E (pt) 1999-09-29 2000-09-29 Prevencao do cancro colorrectal

Country Status (13)

Country Link
US (1) US7851461B2 (pt)
EP (1) EP1220676B1 (pt)
AT (1) ATE294585T1 (pt)
AU (1) AU779996B2 (pt)
CA (1) CA2385755C (pt)
DE (1) DE60019947T2 (pt)
DK (1) DK1220676T3 (pt)
ES (1) ES2240159T3 (pt)
IS (1) IS2488B (pt)
NO (1) NO330061B1 (pt)
NZ (1) NZ517978A (pt)
PT (1) PT1220676E (pt)
WO (1) WO2001022974A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
CA2385755C (en) 1999-09-29 2007-02-06 Colotech A/S Prevention of colorectal cancer
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
AU2002338311B2 (en) * 2001-04-05 2006-08-10 Colotech A/S A combination dosage of a cyclooxygenase (COX) inhibitor, a vitamin D3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer
WO2011024208A1 (en) * 2009-08-24 2011-03-03 Colotech A/S Combination dosage form with acetylsalicylic acid, calcitriol and calcium
EP2515913A2 (en) * 2009-12-23 2012-10-31 Glycomyr Inc. Use of vitamin d glycosides and sulfates for treatment of disease
EP2681311B1 (en) 2011-02-28 2018-03-28 Rigshospitalet, Copenhagen University Hospital Active vitamin d or analogs thereof for use in in vitro fertilization

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205025A1 (en) 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorine derivatives of vitamin D3 and cell differentiation-inducing agents containing the same as an active ingredient
EP0412110B1 (en) 1988-04-21 1993-07-07 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
PL171580B1 (pl) 1991-11-07 1997-05-30 Res Inst Medicine Chem Sposób wytwarzania nowych analogów witaminy D3 PL PL PL
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
DE4334154C2 (de) 1993-10-01 1997-05-22 Schering Ag 2-Halogeno-1,25-dihydroxy-cholecalciferole und pharmazeutische Zusammensetzungen
US6342510B1 (en) 1995-06-12 2002-01-29 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
CA2385755C (en) 1999-09-29 2007-02-06 Colotech A/S Prevention of colorectal cancer

Also Published As

Publication number Publication date
AU779996B2 (en) 2005-02-24
WO2001022974A1 (en) 2001-04-05
CA2385755A1 (en) 2001-04-05
EP1220676B1 (en) 2005-05-04
AU7406300A (en) 2001-04-30
ATE294585T1 (de) 2005-05-15
NO20021437D0 (no) 2002-03-22
ES2240159T3 (es) 2005-10-16
NZ517978A (en) 2003-11-28
IS2488B (is) 2008-12-15
NO20021437L (no) 2002-05-24
DE60019947T2 (de) 2006-02-02
IS6317A (is) 2002-03-20
EP1220676A1 (en) 2002-07-10
US20040116393A1 (en) 2004-06-17
DE60019947D1 (de) 2005-06-09
DK1220676T3 (da) 2005-09-05
CA2385755C (en) 2007-02-06
US7851461B2 (en) 2010-12-14
NO330061B1 (no) 2011-02-14

Similar Documents

Publication Publication Date Title
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
BR0213358A (pt) Uso de flibanserina
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
SI1680128T1 (sl) Mio-inozitol heksafosfat za topično uporabo
BRPI0508333A (pt) uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit
PT1220676E (pt) Prevencao do cancro colorrectal
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
PL368686A1 (en) Novel aminobenzoephenones
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
ME00489B (me) NOVA SINERGIČKA KOMBINACIJA KOJA UKLJUČUJE ROFLUMILAST l FERMOTEROL
PT1389122E (pt) Prevenção do cancro epitelial
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
MXPA05009849A (es) Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
SE0203817D0 (sv) New composition
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
BRPI0509305A (pt) uso de um sensibilizador insulìnico, composição farmecêutica, e , kit
IS7418A (is) Sítalópram til að meðhöndla hækkaðan blóðþrýsting
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
PL1700597T3 (pl) Kompozycja farmaceutyczna do podawania na skórę, zawierająca łącznie ubidekarenon, despantenol oraz chlorheksydynę lub jej farmakologicznie dopuszczalną sól
BRPI0407174A (pt) Regime de administração para nelfinavir
TNSN06068A1 (en) Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application
NO20043774L (no) The use of devazenide as analgesic agent
GT200400014A (es) Metodo de tratamiento con nelfinavir